Adagene Gains NMPA Clearance for ADG138 IND
SAN DIEGO and SUZHOU, China — September 22, 2026 Adagene announced that China’s National Medical Products Administration (NMPA) has...
China
Advertisement
Galderma Advances Restylane Volyme in Chinese Temple Hollowing
ZUG, Switzerland — September 16, 2026 Galderma announced positive topline results from a randomized study evaluating Restylane Volyme, known...
HUTCHMED Reports Phase III SANOVO PFS Benefit in EGFR NSCLC
Hong Kong, Shanghai & Florham Park, NJ – August 31, 2026 HUTCHMED (China) Limited announced positive high-level results from...
Leads Biolabs Advances Opamtistomig Phase II Trial in First-Line Liver Cancer
NANJING, China, August 6, 2026 Leads Biolabs announced that its Phase II clinical study evaluating Opamtistomig (LBL-024) in combination...
enVVeno Medical Advances FDA Pivotal Trial for enVVe System
IRVINE, Calif., July 31, 2026 enVVeno Medical Corporation reported its second quarter 2026 financial results, highlighting significant progress toward...
Advertisements
Leads Biolabs Completes Opamtistomig Phase II Enrollment in BTC
NANJING, China, July 30, 2026 Leads Biolabs announced that its Phase II clinical trial evaluating Opamtistomig (LBL-024), a proprietary...
Delonix Bioworks Doses First Participant in DX-104 Trial
SHANGHAI, China, July 13, 2026 Delonix Bioworks, a clinical-stage biotechnology company specializing in genetically engineered bacterial vaccines, has announced...
Aligos Secures $25M Upfront in Greater China Deal
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...
NKGen Biotech to Highlight Troculeucel Alzheimer’s Program at BIOCHINA Forum
SANTA ANA, Calif., July 2, 2026 NKGen Biotech announced that Chairman and Chief Executive Officer Paul Y. Song, M.D.,...
Advertisement
